Consonance’s Enclara Health Grows Hospice Platform
August 19, 2014
Enclara Health, a hospice-specialty pharmacy services provider in the Consonance Capital Partners portfolio, has acquired excelleRx. Servicing roughly 475 hospice providers and 84,000 hospice patients per day in the U.S., excelleRx and its affiliates utilize a direct-to-patient mail order model along with a local pharmacy benefit manager (PBM) network model that provides access to 65,000 participating pharmacies. Enclara was founded in 2006 and underwent a recapitalization from Consonance earlier this year. excelleRx, which does business as Hospice Pharmacia, had been backed by Omnicare (NYSE: OCR).